![netspot fda netspot fda](https://s3-adacap-product.s3.eu-west-1.amazonaws.com/wp-content/uploads/2018/12/17152700/2014-190x190.jpg)
The use of the eHealthMe site and its content is at your own risk. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The kit contains: Vial 1 (10-mL Ultra inert Type I Plus glass vial, light-blue flip-off cap): 40 mcg of dotatate, 5 mcg 1,10-phenanthroline, 6 mcg gentisic acid, 20 mg mannitol as. PLEASE SCROLL DOWN FOR A STATE-BY STATE LIST OF WHERE THE SCAN IS OFFERED Locations of the Gallium-68 PET/CT scan have been. NETSPOT is supplied as a single-dose kit (NDC 69488-001-40) for preparing a single dose of gallium 68 (Ga 68) radiolabeled dotatate injection. Different individuals may respond to medication in different ways. The US Food and Drug Administration’s (FDA) Japproval of the Gallium-68 PET/CT DOTATATE scan using NETSPOT heralded a new age of nuclear imaging for neuroendocrine tumors in the United States. Our phase IV clinical studies alone cannot establish cause-effect relationship. WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.ÄISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. The FDA granted Priority Review and orphan drug designations for Netspot. No serious adverse reactions have been identified.
![netspot fda netspot fda](https://i0.wp.com/ronnyallan.net/wp-content/uploads/2019/01/merkel-cell-prrt-ga68-images.png)
#NETSPOT FDA SOFTWARE#
Our analysis results are available to researchers, health care professionals, patients ( testimonials), and software developers ( open API). Netspot contributes to overall long-term cumulative radiation exposure, and patients should drink and urinate as often as possible during the first hours following administration to help reduce this risk. Results of our real-world drug study have been referenced on 600+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature.
![netspot fda netspot fda](https://xqimg.imedao.com/170f094767f1220c3fead6cd.jpg)
We study millions of patients and 5,000 more each day. With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials.